Obstetrics, gynecology and reproductive medicine guidelines

Tuberculosis

PubMed Free Full Text

Tuberculosis: treatment

Armenia

• Interdisciplinary Perspectives on Infectious Diseases
  • Reasons for Delay in Seeking Care for Tuberculosis, Republic of Armenia, 2006–2007 [2010]

Brazil

• Jornal Brasileiro de Pneumologia
  • Antituberculosis drugs: drug interactions, adverse effects, and use in special situations - part 2: second line drugs [2010]
  • Antituberculosis drugs: drug interactions, adverse effects, and use in special situations - part 1: first-line drugs [2010]

China

• BMC Public Health
  • Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic review [2011]

Colombia

• Revista Española de Quimioterapia
  • Antimycobacterial natural products--an opportunity for the Colombian biodiversity [2011]

India

• PLoS ONE
  • Are Tuberculosis Patients in a Tertiary Care Hospital in Hyderabad, India Being Managed According to National Guidelines? [2012]

International

• Cochrane Library
  • Routine surgery in addition to chemotherapy for treating spinal tuberculosis
  • Regimens of less than six months for treating tuberculosis
  • Nutritional supplements for people being treated for active tuberculosis
  • Mycobacterium vaccae immunotherapy for treating tuberculosis
  • Material incentives and enablers in the management of tuberculosis
  • Low level laser therapy for treating tuberculosis
  • Isoniazid for preventing tuberculosis in non-HIV infected persons
  • Interventions for treating tuberculous pericarditis
  • Fully intermittent dosing with drugs for treating tuberculosis in adults
  • Directly observed therapy for treating tuberculosis
  • Corticosteroids for tuberculous pleurisy

• Program for Appropriate Technology in Health (PATH)
  • An Advocacy Strategy for Adoption and Dissemination of the WHO Policy on TB Infection Control in Health Care Facilities, Congregate Settings, and Households [2010]

Sub-Saharan Africa

• African Health Sciences
  • A review of compliance to anti tuberculosis treatment and risk factors for defaulting treatment in Sub Saharan Africa [2010]

United Kingdom

• British Thoracic Society
  • BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-{alpha} treatment [2005]

United States of America

• American Thoracic Society
  • An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy [2006]
  • Treatment of Tuberculosis. American Thoracic Society, CDC, and Infectious Diseases Society of America [2003]

• CDC Tuberculosis (TB)
  • TB | Treatment

• Centers for Disease Control and Prevention
  • Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection [2011]

• National Institutes of Health
  • Tuberculosis Biomarker and Surrogate Endpoint Research Roadmap [2011]

• Society of Infectious Diseases Pharmacists
  • Treatment of active pulmonary tuberculosis in adults: current standards and recent advances. Insights from the Society of Infectious Diseases Pharmacists [2009]

WHO

• World Health Organization
  • Treatment of tuberculosis: guidelines [2010]
  • Green Light Committee application instructions [2010]
  • WHO policy on TB infection control in health-care facilities, congregate settings and households [2009]
  • Assessment of human resources and time needed to implement the DOTS strategy for TB control in health facilities : survey instrument and guide to implementation [2008]

Articles in journals

• American Family Physician
  • Update on the Treatment of Tuberculosis [2008]

• Annals of Clinical Microbiology and Antimicrobials
  • Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor [2006]

• Antimicrobial Agents and Chemotherapy
  • Targeting Persisters for Tuberculosis Control [2012]
  • Current Prospects for the Fluoroquinolones as First-Line Tuberculosis Therapy [2011]
  • New Small-Molecule Synthetic Antimycobacterials [2005]
  • Mycobacterium tuberculosis in the Extracellular Compartment: an Underestimated Adversary [2003]

• British Medical Journal
  • Long term efficacy of DOTS regimens for tuberculosis: systematic review [2008]
  • Cost effectiveness analysis of strategies for tuberculosis control in developing countries [2005]
  • Treatment of tuberculosis [2003]
  • Directly observed treatment for tuberculosis [2003]

• Bulletin of the World Health Organization
  • Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience [2012]
  • Treatment of tuberculosis: present status and future prospects [2005]

• Clinical Infectious Diseases
  • Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment? [2011]
  • Rip Van Winkle Wakes Up: Development of Tuberculosis Treatment in the 21st Century [2010]

• Clinical Microbiology Reviews
  • Tuberculosis Chemotherapy: the Influence of Bacillary Stress and Damage Response Pathways on Drug Efficacy [2006]

• European Respiratory Journal
  • Knowledge of tuberculosis-treatment prescription of health workers: a systematic review [2012]
  • Drug-susceptibility testing in tuberculosis: methods and reliability of results [2005]

• Expert Opinion on Pharmacotherapy
  • Tuberculosis pharmacotherapy: strategies to optimize patient care [2009]

• Future Medicinal Chemistry
  • Nitroimidazoles for the treatment of TB: past, present and future [2011]
  • In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TB [2010]

• Indian Journal of Medical Research
  • Current trends in chemotherapy of tuberculosis [2004]

• International Journal of Infectious Diseases
  • Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review [2011]

• Jornal Brasileiro de Pneumologia
  • Severe tuberculosis requiring ICU admission [2012]

• Journal of Antimicrobial Chemotherapy
  • Antitubercular inhaled therapy: opportunities, progress and challenges [2005]

• Journal of Clinical Microbiology
  • Current Perspectives on Drug Susceptibility Testing of Mycobacterium tuberculosis Complex: the Automated Nonradiometric Systems [2006]

• Journal of Pharmacy and Pharmaceutical Sciences
  • Present status of nanoparticle research for treatment of Tuberculosis [2011]
  • An Overview of Tuberculosis Chemotherapy – A Literature Review [2011]

• Lancet Infectious Diseases
  • Sputum Monitoring during Tuberculosis Treatment for Predicting Outcome: A Systematic Review and Meta-analysis [2010]

• Liver Transplantation
  • Tuberculosis in liver transplant recipients: A systematic review and meta-analysis of individual patient data [2009]

• PLoS Medicine
  • Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis [2009]
  • Patient Adherence to Tuberculosis Treatment: A Systematic Review of Qualitative Research [2007]
  • New Approaches to Filling the Gap in Tuberculosis Drug Discovery [2007]
  • Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries [2007]

• PLoS ONE
  • Assessing Tuberculosis Case Fatality Ratio: A Meta-Analysis [2011]

• Proteomics
  • The progress made in determining the Mycobacterium tuberculosis structural proteome [2011]

• Respiratory Research
  • Tuberculosis chemotherapy: current drug delivery approaches [2006]

• Tohoku Journal of Experimental Medicine
  • Development of new anti-tuberculosis drug candidates [2010]

• Trends in Microbiology
  • Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery [2011]
  • Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis [2011]

{Related topics}

• Guidelines
  • Tuberculosis: drug resistance
  • Tuberculosis